NM_130385.4:c.2624A>T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_130385.4(IRAG1):c.2624A>T(p.Tyr875Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_130385.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IRAG1 | ENST00000423302.7 | c.2624A>T | p.Tyr875Phe | missense_variant | Exon 21 of 21 | 2 | NM_130385.4 | ENSP00000412130.2 | ||
IRAG1 | ENST00000534266.6 | c.1679A>T | p.Tyr560Phe | missense_variant | Exon 19 of 19 | 2 | ENSP00000433296.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.2624A>T (p.Y875F) alteration is located in exon 21 (coding exon 21) of the MRVI1 gene. This alteration results from a A to T substitution at nucleotide position 2624, causing the tyrosine (Y) at amino acid position 875 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at